Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107417726B reveals PC-Phos ligand enabling high-yield asymmetric cyclization. Delivers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing.
Patent CN105130982A reveals efficient synthesis route. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN118165059A reveals a novel synthesis for stable DNA monomers. Discover cost-effective manufacturing and reliable supply chain solutions for oligonucleotide production.
Patent CN103642747A details a high-efficiency recombinant E. coli method for chiral alcohol production, offering superior ee >99% and cost-effective cofactor regeneration for pharma supply chains.
Novel process for Aramchol using cholic acid. High optical purity, reduced steps. Ideal for API manufacturing cost reduction and supply chain stability.
Patent CN104672039A introduces a metal-free cyanation method using hypervalent iodine. This breakthrough offers substantial cost reduction and safer supply chain solutions.
Patent CN102850383A details a novel chiral zinc-nitrogen complex enabling efficient asymmetric catalysis for fine chemical manufacturing and supply chain optimization.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Novel 3-step route for Vadadustat intermediate CN110903238A. High purity, scalable Suzuki coupling, cost-effective manufacturing for global supply chains.
Novel copper-catalyzed route for disubstituted urea intermediates. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN110028422B reveals a reversible Michael addition method for amino protection using imidazole hydrochloride, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN112457263A details a metal-free, water-based synthesis of aryl sulfone derivatives, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Advanced quaternary ammonium catalyzed chloromethylation process for high-purity 5-chloromethyl salicylaldehyde. Significant yield improvement and operational ease for global supply chains.
Patent CN102040625B discloses efficient chiral spiro ligands for iridium-catalyzed asymmetric hydrogenation, offering high enantioselectivity and low catalyst loading for pharmaceutical manufacturing.
Patent CN114950452A reveals a novel Co-Y-Ce catalyst for high-purity L-2-aminopropanol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110240551B reveals a high-yield catalytic route for Fmoc-beta-Ala-Gly-OH, offering superior purity and cost efficiency for peptide manufacturing.
Patent CN100537563C reveals a streamlined acid-catalyzed condensation for N-phenyl-2-pyrimidinamine derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115557824A reveals a green palladium-catalyzed route for aryl alkynes using carboxylic acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.